Search

Your search keyword '"Mantello G"' showing total 200 results
Start Over Author "Mantello G"
200 results on '"Mantello G"'

4. PO-2280 Use of Chabner XRT® radiation bra in large-breasted patients: a preliminary experience

Author

di Benedetto, M., primary, Cucciarelli, F., additional, Vagnoni, L., additional, Arena, E., additional, Mariucci, C., additional, Di Carlo, C., additional, Galofaro, C., additional, Agbaje Olufemi, M.V., additional, Panni, V., additional, Parisotto, M., additional, Vicenzi, L., additional, Fenu, F., additional, Valenti, M., additional, and Mantello, G., additional

Published
2023
Full Text
View/download PDF

5. PO-1372 Stereotactic Radiotherapy In Pancreatic Cancer: An Update Of A National Survey

Author

Lucarelli, M., primary, Di Carlo, C., additional, Mantello, G., additional, Osti, M.F., additional, Guido, A., additional, Montrone, S., additional, Bacigalupo, A., additional, Ciabattoni, A., additional, Meduri, B., additional, Macchia, G., additional, Cellini, F., additional, Giaccherini, L., additional, Lupatelli, M., additional, Bignardi, M., additional, Fiore, M., additional, Troiano, M., additional, Simoni, N., additional, Mazzarotto, R., additional, Loi, M., additional, Niespolo, R.M., additional, Borzillo, V., additional, Gerardi, M.A., additional, Comito, T., additional, and Caravatta, L., additional

Published
2023
Full Text
View/download PDF

6. PO-1401 Elderly Anal Cancer Patients Treated With Intensity-Modulated Radiation Therapy: A Multicenter Study

Author

Caravatta, L., primary, Mantello, G., additional, Valvo, F., additional, Franco, P., additional, Gasparini, L., additional, Di Guglielmo, F.C., additional, Slim, N., additional, Manfrida, S., additional, Gambacorta, M.A., additional, De Felice, F., additional, Gerardi, M.A., additional, Vagge, S., additional, Krengli, M., additional, Palazzari, E., additional, Osti, M.F., additional, Gonnelli, A., additional, Catalano, G., additional, Pittoni, P., additional, Ivaldi, G.B., additional, Galardi, A., additional, Lupattelli, M., additional, Rosetto, M.E., additional, Niespolo, R.M., additional, Guido, A., additional, Durante, O., additional, Macchia, G., additional, Munoz, F., additional, Khouzai, B.E., additional, Lucido, M.R., additional, D'Angelillo, R.M., additional, Porreca, A., additional, Di Nicola, M., additional, and Genovesi, D., additional

Published
2023
Full Text
View/download PDF

7. PO-1406 Re-irradiation in locally recurrent rectal cancer: a national survey of the AIRO GI study group

Author

MANTELLO, G., primary, Galofaro, E., additional, Di Carlo, C., additional, Montrone, S., additional, Caravatta, L., additional, De Paoli, A., additional, Gambacorta, M.A., additional, Genovesi, D., additional, Lupattelli, M., additional, Macchia, G., additional, Niespolo, R.M., additional, Valvo, F., additional, Arpa, D., additional, Scricciolo, M., additional, Chiloiro, V., additional, Montesi, G., additional, Pontoriero, A., additional, Donato, V., additional, and Franco, P., additional

Published
2023
Full Text
View/download PDF

11. OC-0272 External validation of the Hemo-Eosinophils-Inflammation index as a prognosticator in anal cancer

Author

Franco, P., primary, Porreca, A., additional, Di Nicola, M., additional, Mantello, G., additional, Valvo, F., additional, Slim, N., additional, Manfrida, S., additional, Gambacorta, M.A., additional, De Felice, F., additional, Vagge, S., additional, Krengli, M., additional, Palazzari, E., additional, Osti, M.F., additional, Gonelli, A., additional, Catalano, G., additional, Pittoni, P., additional, Lupattelli, M., additional, Niespolo, M.R., additional, Rosetto, M.E., additional, Macchia, G., additional, Durante, O., additional, Munoz, F., additional, D'Angelillo, R.M., additional, Genovesi, D., additional, and Caravatta, L., additional

Published
2022
Full Text
View/download PDF

12. OC-0620 A multicenter study on Intensity Modulated Radiotherapy techniques for anal carcinoma (RAINSTORM).

Author

Caravatta, L., primary, Mantello, G., additional, Valvo, F., additional, Pierfrancesco, F., additional, Lucrezia, G., additional, Rosa, C., additional, Slim, N., additional, Pittoni, P., additional, De Felice, F., additional, Gerardi, M.A., additional, Vagge, S., additional, Krengli, M., additional, Palazzari, E., additional, Osti, M.F., additional, Catalano, G., additional, Ivaldi, G.B., additional, Galardi, A., additional, Lupattelli, M., additional, Niespolo, R.M., additional, Guido, A., additional, Macchia, G., additional, Gambacorta, M.A., additional, Di Nicola, M., additional, Donato, V., additional, and Genovesi, D., additional

Published
2021
Full Text
View/download PDF

19. Correction to: Long-Term Outcomes of Local Excision Following Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer (Annals of Surgical Oncology, (2021), 28, 5, (2801-2808), 10.1245/s10434-020-09243-6)

Author

D'Alimonte, L., Bao, Q. R., Spolverato, G., Capelli, Giovanni, Del Bianco, P., Albertoni, L., De Paoli, A., Guerrieri, M., Mantello, G., Gambacorta, Maria Antonietta, Canzonieri, V., Valentini, Vincenzo, Coco, Claudio, and Pucciarelli, S.

Subjects
N/A, Settore MED/36 - DIAGNOSTICA PER IMMAGINI E RADIOTERAPIA
Published
2021

21. Long-Term Outcomes of Local Excision Following Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer

Author

D'Alimonte, L., Bao, Q. R., Spolverato, G., Capelli, Giovanni, Del Bianco, P., Albertoni, L., De Paoli, A., Guerrieri, M., Mantello, G., Gambacorta, Maria Antonietta, Canzonieri, V., Valentini, Vincenzo, Coco, Claudio, Pucciarelli, S., Capelli G., Gambacorta M. A. (ORCID:0000-0001-5455-8737), Valentini V. (ORCID:0000-0003-4637-6487), Coco C. (ORCID:0000-0002-4713-7093), D'Alimonte, L., Bao, Q. R., Spolverato, G., Capelli, Giovanni, Del Bianco, P., Albertoni, L., De Paoli, A., Guerrieri, M., Mantello, G., Gambacorta, Maria Antonietta, Canzonieri, V., Valentini, Vincenzo, Coco, Claudio, Pucciarelli, S., Capelli G., Gambacorta M. A. (ORCID:0000-0001-5455-8737), Valentini V. (ORCID:0000-0003-4637-6487), and Coco C. (ORCID:0000-0002-4713-7093)

Abstract

Background: Local excision might represent an alternative to total mesorectal excision for patients with locally advanced rectal cancer who achieve a major or complete clinical response after neoadjuvant chemoradiotherapy. Methods: Between August 2005 and July 2011, 63 patients with mid-low rectal adenocarcinoma who had a major/complete clinical response after neoadjuvant chemoradiotherapy were enrolled in a multicenter prospective phase 2 trial and underwent transanal full thickness local excision. The main endpoint of this study was to evaluate the 5- and 10-year overall, relapse-free, local, and distant relapse-free survival, which were calculated by applying the Kaplan–Meier method. The rate of patients with rectum preserved and without stoma were also calculated. Results: Of 63 patients, 38 (60%) were male and 25 (40%) were female, with a median (range) age of 64 (25–82) years. At baseline, the following clinical stages were found: cT2, n = 21 (33.3%); cT3, n = 42 (66.6%), 39 (61.9%) patients were cN+. At a median (range) follow-up of 108 (32–166) months, the estimated cumulative 5- and 10-year overall survival, relapse-free survival, local recurrence-free survival, and distant recurrence-free survival were 87% (95% CI 76–93) and 79% (95% CI 66–87), 89% (95% CI 78–94) and 82% (95% CI 66–91), both 91% (95% CI 81–96), and 90% (95% CI 80–95) and 86% (95% CI 73–93), respectively. Overall, 49 (77.8%) patients had their rectum preserved, and 54 (84.1%) were stoma-free. Conclusion: In highly selected patients, the local excision approach after neoadjuvant chemoradiotherapy is associated with excellent long-term outcomes, high rates of rectum preservation and absence of permanent stoma.

Published
2021

22. Radiotherapy with intensity-modulated (Imrt) techniques in the treatment of anal carcinoma (rainstorm): A multicenter study on behalf of airo (Italian association of radiotherapy and clinical oncology) gastrointestinal study group

Author

Caravatta, L., Mantello, G., Valvo, F., Franco, P., Gasparini, L., Rosa, C., Slim, N., Manfrida, S., De Felice, F., Gerardi, M. A., Vagge, S., Krengli, M., Palazzari, E., Osti, M. F., Gonnelli, A., Catalano, G., Pittoni, P., Ivaldi, G. B., Galardi, A., Lupattelli, M., Rosetto, M. E., Niespolo, R. M., Guido, A., Durante, O., Macchia, G., Munoz, F., El Khouzai, B., Lucido, M. R., Porreca, A., Di Nicola, M., Gambacorta, M. A., Donato, V., Genovesi, D., Manfrida S., Macchia G., Porreca A., Gambacorta M. A. (ORCID:0000-0001-5455-8737), Caravatta, L., Mantello, G., Valvo, F., Franco, P., Gasparini, L., Rosa, C., Slim, N., Manfrida, S., De Felice, F., Gerardi, M. A., Vagge, S., Krengli, M., Palazzari, E., Osti, M. F., Gonnelli, A., Catalano, G., Pittoni, P., Ivaldi, G. B., Galardi, A., Lupattelli, M., Rosetto, M. E., Niespolo, R. M., Guido, A., Durante, O., Macchia, G., Munoz, F., El Khouzai, B., Lucido, M. R., Porreca, A., Di Nicola, M., Gambacorta, M. A., Donato, V., Genovesi, D., Manfrida S., Macchia G., Porreca A., and Gambacorta M. A. (ORCID:0000-0001-5455-8737)

Abstract

A multi-institutional retrospective study was conducted to evaluate the pattern of care and clinical outcomes of anal cancer patients treated with intensity-modulated radiotherapy (IMRT) techniques. In a cohort of 987 patients, the clinical complete response (CR) rate (beyond 6 months) was 90.6%. The 3-year local control (LC) rate was 85.8% (95% CI: 84.4–87.2), and the 3-year colostomy-free survival (CFS) rate was 77.9% (95% CI: 76.1–79.8). Three-year progression-free survival (PFS) and overall survival (OS) rates were 80.2% and 88.1% (95% CI: 78.8–89.4) (95% CI: 78.5–81.9), respectively. Histological grade 3 and nodal involvement were associated with lower CR (p = 0.030 and p = 0.004, respectively). A statistically significant association was found between advanced stage and nodal involvement, and LC, CFS, PFS, OS and event-free survival (EFS). Overall treatment time (OTT) ≥45 days showed a trend for a lower PFS (p = 0.050) and was significantly associated with lower EFS (p = 0.030) and histological grade 3 with a lower LC (p = 0.025). No statistically significant association was found between total dose, dose/fraction and/or boost modality and clinical outcomes. This analysis reports excellent clinical results and a mild toxicity profile, confirming IMRT techniques as standard of care for the curative treatment of anal cancer patients. Lymph node involvement and histological grade have been confirmed as the most important negative prognostic factors.

Published
2021

23. Treatment volume, dose prescription and delivery techniques for dose-intensification in Rectal Cancer: A national survey

Author

Caravatta, L., Lupattelli, M., Mantello, G., Gambacorta, Maria Antonietta, Chiloiro, Giuditta, Di Tommaso, M., Rosa, C., Gasparini, L., Morganti, Alessio Giuseppe, Picardi, V., Niespolo, R. M., Osti, M. F., Montrone, S., Simoni, N., Boso, C., Facchin, F., Deidda, M. A., Piva, C., Guida, C., Ziccarelli, L., Munoz, F., Ivaldi, G. B., Marchetti, V., Franzone, P., Spatola, C., Franco, P., Donato, V., Genovesi, D., Gambacorta M. A. (ORCID:0000-0001-5455-8737), Chiloiro G., Morganti A. G., Caravatta, L., Lupattelli, M., Mantello, G., Gambacorta, Maria Antonietta, Chiloiro, Giuditta, Di Tommaso, M., Rosa, C., Gasparini, L., Morganti, Alessio Giuseppe, Picardi, V., Niespolo, R. M., Osti, M. F., Montrone, S., Simoni, N., Boso, C., Facchin, F., Deidda, M. A., Piva, C., Guida, C., Ziccarelli, L., Munoz, F., Ivaldi, G. B., Marchetti, V., Franzone, P., Spatola, C., Franco, P., Donato, V., Genovesi, D., Gambacorta M. A. (ORCID:0000-0001-5455-8737), Chiloiro G., and Morganti A. G.

Abstract

Background/Aim: The aim of the study was to investigate boost volume definition, doses, and delivery techniques for rectal cancer dose intensification. Patients and Methods: An online survey was made on 25 items (characteristics, simulation, imaging, volumes, doses, planning and treatment). Results: Thirty-eight radiation oncologists joined the study. Twenty-one delivered long-course radiotherapy with dose intensification. Boost volume was delineated on diagnostic magnetic resonance imaging (MRI) in 18 centres (85.7%), and computed tomography (CT) and/or positron emission tomography-CT in 9 (42.8%); 16 centres (76.2%) performed co-registration with CT-simulation. Boost dose was delivered on gross tumor volume in 10 centres (47.6%) and on clinical target volume in 11 (52.4%). The most common total dose was 54-55 Gy (71.4%), with moderate hypofractionation (85.7%). Intensity-modulated radiotherapy (IMRT) was used in all centres, with simultaneous integrated boost in 17 (80.8%) and image-guidance in 18 (85.7%). Conclusion: A high quality of treatment using dose escalation can be inferred by widespread multidisciplinary discussion, MRI-based treatment volume delineation, and radiation delivery relying on IMRT with accurate image-guided radiation therapy protocols.

Published
2021

29. PO-0976: Left sided breast cancer patients and advanced radiotherapy techniques. A cardiac sparing approach.

Author

Cucciarelli, F., primary, Parisotto, M., additional, Costantini, S., additional, Di Carlo, C., additional, Fenu, F., additional, Di Biase, S., additional, Vicenzi, L., additional, Di Benedetto, M., additional, Maucieri, A., additional, Montisci, M., additional, Morabito, V.E., additional, Valenti, M., additional, Maggi, S., additional, and Mantello, G., additional

Published
2020
Full Text
View/download PDF

34. EP-1463 Radiation dose intensification in rectal cancer: a survey by the AIRO gastrointestinal study group

Author

Caravatta, L., primary, Gambacorta, M.A., additional, Mantello, G., additional, Lupattelli, M., additional, Di Tommaso, M., additional, Consuelo, R., additional, Macchia, G., additional, De Paoli, A., additional, Niespolo, R.M., additional, Dionisi, F., additional, Rosetto, M.E., additional, Valvo, F., additional, Osti, M.F., additional, Morganti, A.G., additional, Valentini, V., additional, and Genovesi, D., additional

Published
2019
Full Text
View/download PDF

35. PO-0809 Gross Tumor Volume delineation in pancreatic cancer using MRI: final results of a multicenter study.

Author

Caravatta, L., primary, Cellini, F., additional, Simoni, N., additional, Rosa, C., additional, Niespolo, R.M., additional, Lupattelli, M., additional, Picardi, V., additional, Macchia, G., additional, Sainato, A., additional, Mantello, G., additional, Dionisi, F., additional, Rosetto, M.E., additional, Fusco, V., additional, Navarria, F., additional, De Paoli, A., additional, Guido, A., additional, Vecchi, C., additional, Basilico, R., additional, Cianci, R., additional, Pizzi, A. Delli, additional, Di Nicola, M., additional, Mattiucci, G.C., additional, Valentini, V., additional, Morganti, A.G., additional, and Genovesi, D., additional

Published
2019
Full Text
View/download PDF

37. PO-0775: MRI for GTV delineation in pancreatic cancer: preliminary results of a multi-institutional study

Author

Caravatta, L., primary, Cellini, F., additional, Simoni, N., additional, Rosa, C., additional, Niespolo, R., additional, Lupattelli, M., additional, Picardi, V., additional, Macchia, G., additional, Sainato, A., additional, Mantello, G., additional, Dionisi, F., additional, Rosetto, M.E., additional, Guida, C., additional, Basilico, R., additional, De Paoli, A., additional, Boz, G., additional, Fusco, V., additional, Mattiucci, G.C., additional, Morganti, A.G., additional, and Genovesi, D., additional

Published
2018
Full Text
View/download PDF

38. Time to surgery and pathologic complete response after neoadjuvant chemoradiation in rectal cancer: A population study on 2094 patients

Author

Macchia, G., Gambacorta, Maria Antonietta, Masciocchi, Carlotta, Chiloiro, Giuditta, Mantello, G., Di Giambenedetto, Simona, Lupattelli, M., Palazzari, E., Belgioia, L., Bacigalupo, Andrea, Sainato, A., Montrone, S., Turri, L., Caroli, A., De Paoli, A., Matrone, F., Capirci, C., Montesi, G., Niespolo, R. M., Osti, M. F., Caravatta, L., Galardi, A., Genovesi, D., Rosetto, M. E., Boso, C., Sciacero, P., Giaccherini, L., Parisi, S., Fontana, A., Filippone, F. R., Picardi, V., Morganti, A. G., Valentini, Vincenzo, Gambacorta M. A. (ORCID:0000-0001-5455-8737), Masciocchi C., Chiloiro G., di Benedetto M. (ORCID:0000-0001-6990-5076), Bacigalupo A. (ORCID:0000-0002-9119-567X), Valentini V. (ORCID:0000-0003-4637-6487), Macchia, G., Gambacorta, Maria Antonietta, Masciocchi, Carlotta, Chiloiro, Giuditta, Mantello, G., Di Giambenedetto, Simona, Lupattelli, M., Palazzari, E., Belgioia, L., Bacigalupo, Andrea, Sainato, A., Montrone, S., Turri, L., Caroli, A., De Paoli, A., Matrone, F., Capirci, C., Montesi, G., Niespolo, R. M., Osti, M. F., Caravatta, L., Galardi, A., Genovesi, D., Rosetto, M. E., Boso, C., Sciacero, P., Giaccherini, L., Parisi, S., Fontana, A., Filippone, F. R., Picardi, V., Morganti, A. G., Valentini, Vincenzo, Gambacorta M. A. (ORCID:0000-0001-5455-8737), Masciocchi C., Chiloiro G., di Benedetto M. (ORCID:0000-0001-6990-5076), Bacigalupo A. (ORCID:0000-0002-9119-567X), and Valentini V. (ORCID:0000-0003-4637-6487)

Abstract

Background To retrospectively evaluate the difference in terms of pathologic complete response (pCR) according to time elapsed between chemoradiation (CRT) and total mesorectal excision (TME) on a large unselected real-life dataset of locally advanced rectal cancer (LARC) patients. Methods A multicentre retrospective cohort study of LARC patients from 21 Italian Radiotherapy Institutions was performed. Patients were stratified into 3 different time intervals from CRT. The 1st group included 300 patients who underwent TME within 6 weeks, the 2nd 1598 patients (TME within 7–12 weeks) and the 3rd 196 patients (TME within 13 or more weeks after CRT), respectively. Results Data on 2094 LARC patients treated between 1997 and 2016 were considered suitable for analysis. Overall, 578 patients had stage II while 1516 had stage III histological proven invasive rectal adenocarcinoma. A CRT schedule of one agent (N = 1585) or 2-drugs (N = 509) was administered. Overall, pCR was 22.3% (N = 468 patients). The proportion of patients achieving pCR with respect to time interval was, as follows: 12.6% (1st group), 23% (2nd group) and 31.1% (3rd group) (p < 0.001), respectively. The pCR relative risk comparison of 2nd to 1st group was 1.8, while 3rd to 2nd group was 1.3. Moreover, between the 3rd and 1st group, a pCR relative risk of 2.4 (p < 0.01) was noted. At univariate analysis, clinical stage III (p < 0.001), radiotherapy dose >5040 cGy (p = 0.002) and longer interval (p < 0.001) were significantly correlated to pCR. The positive impact of interval (p < 0.001) was confirmed at multivariate analysis as the only correlated factor. Conclusion We confirmed on a population-level that lengthening the interval (>13 weeks) from CRT to surgery improves the pathological response (pCR and pathologic partial response; pPR) in comparison to historic data. Furthermore, radiotherapy dose >5040 cGy and two drugs chemotherapy correlated with pPR rate.

Published
2017

39. PV-0326: Time to surgery and pCR after neoadjuvant CRT in rectal cancer: a population study on 2113 patients

Author

Macchia, G., primary, Gambacorta, M., additional, Chiloiro, G., additional, Mantello, G., additional, De Paoli, A., additional, Montesi, G., additional, Sainato, A., additional, Lupattelli, M., additional, Caravatta, L., additional, Perrotti, F., additional, Rosetto, M., additional, Filippone, F., additional, Niespolo, R., additional, Osti, M., additional, Belgioia, L., additional, Boso, C., additional, Fontana, A., additional, Parisi, S., additional, Galardi, A., additional, Turri, L., additional, Sciacero, P., additional, Giaccherini, L., additional, Masciocchi, C., additional, Morganti, A., additional, and Valentini, V., additional

Published
2017
Full Text
View/download PDF

41. OC-0243: Randomised trial on preoperative platin-based Radiochemotherapy in rectal cancer: 10-years analysis

Author

Gambacorta, M., primary, Cellini, F., additional, Colangione, M., additional, Lupattelli, M., additional, Lancellotta, V., additional, Genovesi, D., additional, Cosimelli, M., additional, Picardi, V., additional, Osti, M., additional, Portaluri, M., additional, Tramacere, F., additional, Maranzano, E., additional, Mantello, G., additional, and Valentini, V., additional

Published
2016
Full Text
View/download PDF

44. Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey

Author

Macchia, Gabriella, Sainato, A, Talamini, R, Boz, G, Bacigalupo, A, Caravatta, Luciana, Fiore, M, Friso, Ml, Fusco, Vincenzo, Lupattelli, M, Mantello, G, Mattiucci, Gian Carlo, Slim, N, Sciacero, P, Turri, L, Valentini, Vincenzo, Morganti, Alessio Giuseppe, Genovesi, D., Mattiucci, Gian Carlo (ORCID:0000-0001-6500-0413), Valentini, Vincenzo (ORCID:0000-0003-4637-6487), Macchia, Gabriella, Sainato, A, Talamini, R, Boz, G, Bacigalupo, A, Caravatta, Luciana, Fiore, M, Friso, Ml, Fusco, Vincenzo, Lupattelli, M, Mantello, G, Mattiucci, Gian Carlo, Slim, N, Sciacero, P, Turri, L, Valentini, Vincenzo, Morganti, Alessio Giuseppe, Genovesi, D., Mattiucci, Gian Carlo (ORCID:0000-0001-6500-0413), and Valentini, Vincenzo (ORCID:0000-0003-4637-6487)

Abstract

No information is currently available regarding pancreatic cancer (PC) pattern of care in Italy. In the present study, a nationwide survey using a questionnaire was performed to enquire the local standards for PC diagnosis and radiotherapy treatment. Fifty-seven percent of 140 Italian centres completed questionnaire. The main causes of no radiotherapy indication were poor general condition (45%) and lack of guidelines (25%). Physicians (38%) employed neoadjuvant therapy in locally advanced PC patients, while in other centres (62%) adjuvant chemoradiation was administered. Adjuvant gemcitabine-based chemotherapy was selected as the treatment of choice by 59% of centres. Patients were treated mostly with doses of 50-54.9 Gy on the tumour (or bed) plus lymph nodes. A 3D-CRT technique was used in 81.2% of centres, while IMRT and IGRT were available in 61.2 and 48.7% of cases, respectively. Extensive variation exists with regard to patterns of care for PC in Italy. Nevertheless, cooperative studies emerging from this survey appeared beneficial.

Published
2015

45. La Radioterapia dei Tumori Gastrointestinali. Indicazioni e Criteri Guida

Author

Genovesi, D, Turri, L, De Paoli, A, Mattiucci, Gc, Macchia, G, Sainato, A, Lupattelli, M, Osti, Mf, Friso, Ml, Gambacorta, Ma, Mantello, G, Valvo, F, Niespolo, R, Dionisi, F, Guarneri, A, Agolli, L, Arcangeli, G, Argurio, A, Bacigalupo, A, Boz, G, Capirci, C, Caravatta, L, Ciabattoni, A, Coppola, M, Corti, L, Dell'Acqua, V, Galardi, A, Giannini, M, Innocente, R, Leonardi, Mc, Musio, D, Pani, G, Rosetto, Me, Scandolaro, L, Sciacero, P, Aristei, C, Cionini, L, Corvò, R, Morganti, Ag, Pergolizzi, Stefano, Ricardi, U, and Valentini, V.

Published
2012

50. Four years with FALCON - an ESTRO educational project: achievements and perspectives

Author

Eriksen, Jg, Salembier, C, Rivera, S, De Bari, B, Berger, D, Mantello, G, Müller, A, Martin, An, Pasini, Danilo, Tanderup, K, Palmu, M, Verfaillie, C, Pötter, R, Valentini, Vincenzo, Valentini, Vincenzo (ORCID:0000-0003-4637-6487), Eriksen, Jg, Salembier, C, Rivera, S, De Bari, B, Berger, D, Mantello, G, Müller, A, Martin, An, Pasini, Danilo, Tanderup, K, Palmu, M, Verfaillie, C, Pötter, R, Valentini, Vincenzo, and Valentini, Vincenzo (ORCID:0000-0003-4637-6487)

Abstract

Variability in anatomical contouring is one of the important uncertainties in radiotherapy. FALCON (Fellowship in Anatomic deLineation and CONtouring) is an educational ESTRO (European SocieTy for Radiation and Oncology) project devoted to improve interactive teaching, the homogeneity in contouring and to compare individual contours with endorsed guidelines or expert opinions. This report summarizes the experience from the first 4 years using FALCON for educational activities within ESTRO School and presents the perspectives for the future.

Published
2014

Catalog

Books, media, physical & digital resources
See catalog results